All blog posts
Total 57 results for
Showing 36 out of 57 results
15 June 2020
Unsuccessful strike out of a quia timet infringement counterclaim
11 June 2020
The rock misses its target in this story of “David and Goliath” – the UK High Court's consideration of interim injunctions in Neurim Pharmaceuticals v Mylan
21 May 2020
Pepper trumps Broccoli: EPO finds products produced by essentially biological processes are not patentable
18 May 2020
COVID-19: PRESSURE POINTS: Developments at Patent Courts in Europe in light of the health emergency (UK, Germany, France, Italy & the EPO)
12 May 2020
Patent and Pharma Update, May 2020
06 May 2020
Update on medicines and medical devices regulation in the EU and the UK and the impact of COVID-19
30 April 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
22 April 2020
COVID-19: Pressure Points: The UK Government confirms that it will indemnify ventilator manufacturers against IP infringement claims
22 April 2020
The UK will not participate in the UPC confirms IP Minister responding to House of Lords' letter
14 April 2020
The impact of COVID-19 on competition law in the pharmaceutical sector
08 April 2020
COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)
08 April 2020
COVID-19: Pressure Points: A Catalyst for Collaboration (Global)
Showing 36 out of 57 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris, Korea Group and Africa Group
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London